Clinical Study

Analysis of Serum and Urinal Copper and Zinc in Chinese Northeast Population with the Prediabetes or Diabetes with and without Complications

Table 4

Associations between serum Cu or urinary Cu level as a continuous variable and laboratory parameters in T2D subjects.

T2D Con ( )DN ( )DR ( )DPN ( )
CuUCuCuUCuCuUCuCuUCu

Glu0.0950.624−0.1800.3510.2890.1710.3210.1270.0160.9290.1290.4680.2960.037*0.0460.753
HbA1c0.3820.041*−0.3070.1060.4400.032*0.1940.3650.4060.017*0.0310.8630.630<0.001*0.1610.264
RBC−0.1380.477−0.0800.679−0.1360.5250.1340.532−0.0390.828−0.0930.6010.0170.9060.1270.381
Hb0.0930.63−0.1330.491−0.1450.5000.0840.6970.1250.483−0.0060.971−0.0310.8330.0730.612
UCu−0.2100.273−0.0670.7550.1160.5140.2580.071
Zn0.3420.0690.1170.1680.2810.184−0.4930.014*0.1050.553−0.1950.2700.2190.1270.1360.347
UZn0.2240.2430.5450.382−0.4810.017*0.1790.403−0.0480.7860.0280.8730.3270.021*0.3190.024*
BUN0.0420.8280.3500.0620.0870.6870.1520.4790.0330.854−0.1460.4110.2000.1640.1480.305
Cre−0.3220.0890.2830.137−0.1640.4450.0530.8070.0200.9120.2610.137−0.0990.4920.3200.023*
eGFR0.0830.670−0.3720.047*0.0400.852−0.1150.5910.0860.630−0.1090.5390.0680.641−0.2760.052
CHO−0.3210.0900.0750.6990.1540.472−0.1170.5860.0100.955−0.1730.3290.1920.1810.0770.595
TG−0.1520.4330.0610.7520.0800.711−0.2780.1890.0160.930−0.0920.6070.1480.307−0.0580.689
HDL0.1470.446−0.0490.799−0.0900.6750.4200.041*0.1890.286−0.2730.1180.1070.459−0.0380.795
LDL−0.3970.033*0.0490.8000.1980.3530.1970.3570.1320.4570.0030.9860.1980.1680.1560.281

Data presentation and abbreviations spelt out forms are the same as the description for Table 1. * for the association.